ZB716, a steroidal selective estrogen receptor degrader (SERD), is orally efficacious in blocking tumor growth in mouse xenograft models.
| Image |  |
|---|---|
| Description | scientific article published on 8 January 2018 |
| Author/s |
author: Lucio Miele |
| Publication date | January 8, 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |